PubMed@dpavot:32965395_en_relations JSONTXT

Annnotations TAB JSON ListView MergeView

ENG_RE

Id Subject Object Predicate Lexical cue
T0 44-48 CHEBI_50906 denotes role
T1 56-63 DOID_4 denotes disease
T2 64-72 HP_0012824 denotes severity
T3 90-98 DOID_0080600 denotes COVID-19
T4 267-278 CHEBI_64360 denotes tocilizumab
T5 404-412 DOID_0080600 denotes COVID-19
T6 503-514 CHEBI_64360 denotes tocilizumab
T7 584-592 HP_0012826 denotes moderate
T8 596-602 HP_0012828 denotes severe
T9 603-611 DOID_0080600 denotes COVID-19
T10 736-744 CHEBI_82594 denotes ferritin
T11 761-768 CHEBI_24996 denotes lactate
T12 930-938 DOID_0080600 denotes COVID-19
T13 1163-1170 HP_0030645 denotes central
T14 1562-1583 GO_0006954 denotes inflammatory response
T15 1587-1595 DOID_0080600 denotes COVID-19
R0 T14 T2 no_relation inflammatory response,severity
R1 T14 T7 no_relation inflammatory response,moderate
R2 T14 T8 no_relation inflammatory response,severe
R3 T1 T0 effect disease,role
R4 T1 T4 effect disease,tocilizumab
R5 T1 T6 effect disease,tocilizumab
R6 T1 T10 effect disease,ferritin
R7 T1 T11 effect disease,lactate
R8 T3 T0 no_relation COVID-19,role
R9 T3 T4 effect COVID-19,tocilizumab
R10 T3 T6 effect COVID-19,tocilizumab
R11 T3 T10 effect COVID-19,ferritin
R12 T3 T11 effect COVID-19,lactate
R13 T5 T0 no_relation COVID-19,role
R14 T5 T4 effect COVID-19,tocilizumab
R15 T5 T6 effect COVID-19,tocilizumab
R16 T5 T10 effect COVID-19,ferritin
R17 T5 T11 effect COVID-19,lactate
R18 T9 T0 no_relation COVID-19,role
R19 T9 T4 effect COVID-19,tocilizumab
R20 T9 T6 effect COVID-19,tocilizumab
R21 T9 T10 effect COVID-19,ferritin
R22 T9 T11 effect COVID-19,lactate
R23 T12 T0 no_relation COVID-19,role
R24 T12 T4 effect COVID-19,tocilizumab
R25 T12 T6 no_relation COVID-19,tocilizumab
R26 T12 T10 no_relation COVID-19,ferritin
R27 T12 T11 no_relation COVID-19,lactate
R28 T15 T0 no_relation COVID-19,role
R29 T15 T4 effect COVID-19,tocilizumab
R30 T15 T6 no_relation COVID-19,tocilizumab
R31 T15 T10 no_relation COVID-19,ferritin
R32 T15 T11 no_relation COVID-19,lactate

ENG_RE_Diana

Id Subject Object Predicate Lexical cue
T0 44-48 CHEBI_50906 denotes role
T1 56-63 DOID_4 denotes disease
T2 64-72 HP_0012824 denotes severity
T3 90-98 DOID_0080600 denotes COVID-19
T4 267-278 CHEBI_64360 denotes tocilizumab
T5 404-412 DOID_0080600 denotes COVID-19
T6 503-514 CHEBI_64360 denotes tocilizumab
T7 584-592 HP_0012826 denotes moderate
T8 596-602 HP_0012828 denotes severe
T9 603-611 DOID_0080600 denotes COVID-19
T10 736-744 CHEBI_82594 denotes ferritin
T11 761-768 CHEBI_24996 denotes lactate
T12 930-938 DOID_0080600 denotes COVID-19
T13 1163-1170 HP_0030645 denotes central
T14 1562-1583 GO_0006954 denotes inflammatory response
T15 1587-1595 DOID_0080600 denotes COVID-19
R0 T14 T2 no_relation inflammatory response,severity
R1 T14 T7 no_relation inflammatory response,moderate
R2 T14 T8 no_relation inflammatory response,severe
R3 T1 T0 effect disease,role
R4 T1 T4 effect disease,tocilizumab
R5 T1 T6 effect disease,tocilizumab
R6 T1 T10 effect disease,ferritin
R7 T1 T11 effect disease,lactate
R8 T3 T0 no_relation COVID-19,role
R9 T3 T4 effect COVID-19,tocilizumab
R10 T3 T6 effect COVID-19,tocilizumab
R11 T3 T10 effect COVID-19,ferritin
R12 T3 T11 effect COVID-19,lactate
R13 T5 T0 no_relation COVID-19,role
R14 T5 T4 effect COVID-19,tocilizumab
R15 T5 T6 effect COVID-19,tocilizumab
R16 T5 T10 effect COVID-19,ferritin
R17 T5 T11 effect COVID-19,lactate
R18 T9 T0 no_relation COVID-19,role
R19 T9 T4 effect COVID-19,tocilizumab
R20 T9 T6 effect COVID-19,tocilizumab
R21 T9 T10 effect COVID-19,ferritin
R22 T9 T11 effect COVID-19,lactate
R23 T12 T0 no_relation COVID-19,role
R24 T12 T4 effect COVID-19,tocilizumab
R25 T12 T6 no_relation COVID-19,tocilizumab
R26 T12 T10 no_relation COVID-19,ferritin
R27 T12 T11 no_relation COVID-19,lactate
R28 T15 T0 no_relation COVID-19,role
R29 T15 T4 effect COVID-19,tocilizumab
R30 T15 T6 no_relation COVID-19,tocilizumab
R31 T15 T10 no_relation COVID-19,ferritin
R32 T15 T11 no_relation COVID-19,lactate

ENG_RE_pruas

Id Subject Object Predicate Lexical cue
T0 44-48 CHEBI_50906 denotes role
T1 56-63 DOID_4 denotes disease
T10 736-744 CHEBI_82594 denotes ferritin
T11 761-768 CHEBI_24996 denotes lactate
T12 930-938 DOID_0080600 denotes COVID-19
T13 1163-1170 HP_0030645 denotes central
T14 1562-1583 GO_0006954 denotes inflammatory response
T15 1587-1595 DOID_0080600 denotes COVID-19
T2 64-72 HP_0012824 denotes severity
T3 90-98 DOID_0080600 denotes COVID-19
T4 267-278 CHEBI_64360 denotes tocilizumab
T5 404-412 DOID_0080600 denotes COVID-19
T6 503-514 CHEBI_64360 denotes tocilizumab
T7 584-592 HP_0012826 denotes moderate
T8 596-602 HP_0012828 denotes severe
T9 603-611 DOID_0080600 denotes COVID-19
T16 106-133 CHEBI_67079 denotes anti-inflammatory therapies
T17 186-219 GO_0002526 denotes uncontrolled inflammatory cascade
T18 90-98 HP_0033141 denotes COVID-19
T19 404-412 HP_0033141 denotes COVID-19
T20 603-611 HP_0033141 denotes COVID-19
T21 930-938 HP_0033141 denotes COVID-19
T22 1587-1595 HP_0033141 denotes COVID-19
R2 T14 T8 no_relation inflammatory response,severe
R20 T9 T6 effect COVID-19,tocilizumab
R21 T9 T10 effect COVID-19,ferritin
R22 T9 T11 effect COVID-19,lactate
R23 T12 T0 no_relation COVID-19,role
R24 T12 T4 effect COVID-19,tocilizumab
R25 T12 T6 no_relation COVID-19,tocilizumab
R26 T12 T10 no_relation COVID-19,ferritin
R27 T12 T11 no_relation COVID-19,lactate
R28 T15 T0 no_relation COVID-19,role
R29 T15 T4 effect COVID-19,tocilizumab
R30 T15 T6 no_relation COVID-19,tocilizumab
R31 T15 T10 no_relation COVID-19,ferritin
R32 T15 T11 no_relation COVID-19,lactate
R4 T1 T4 effect disease,tocilizumab
R5 T1 T6 effect disease,tocilizumab
R6 T1 T10 effect disease,ferritin
R7 T1 T11 effect disease,lactate
R8 T3 T0 no_relation COVID-19,role
R9 T3 T4 effect COVID-19,tocilizumab
R33 T16 T17 effect anti-inflammatory therapies,uncontrolled inflammatory cascade
R34 T8 T20 effect severe,COVID-19
R35 T7 T20 effect moderate,COVID-19
R36 T7 T9 effect moderate,COVID-19
R37 T8 T9 effect severe,COVID-19
R38 T22 T14 effect COVID-19,inflammatory response
R39 T15 T14 effect COVID-19,inflammatory response
R0 T14 T2 no_relation inflammatory response,severity
R1 T14 T7 no_relation inflammatory response,moderate
R10 T3 T6 effect COVID-19,tocilizumab
R11 T3 T10 effect COVID-19,ferritin
R12 T3 T11 effect COVID-19,lactate
R13 T5 T0 no_relation COVID-19,role
R14 T5 T4 effect COVID-19,tocilizumab
R15 T5 T6 effect COVID-19,tocilizumab
R16 T5 T10 effect COVID-19,ferritin
R17 T5 T11 effect COVID-19,lactate
R18 T9 T0 no_relation COVID-19,role
R19 T9 T4 effect COVID-19,tocilizumab

RELASIGEBLAH7hhaider5

Id Subject Object Predicate Lexical cue
T0 44-48 CHEBI_50906 denotes role
T1 56-63 DOID_4 denotes disease
T10 736-744 CHEBI_82594 denotes ferritin
T12 930-938 DOID_0080600 denotes COVID-19
T13 1163-1170 HP_0030645 denotes central
T14 1562-1583 GO_0006954 denotes inflammatory response
T15 1587-1595 DOID_0080600 denotes COVID-19
T16 0-24 DOID_0080600 denotes Pro-inflammatory markers
T2 64-72 HP_0012824 denotes severity
T3 90-98 DOID_0080600 denotes COVID-19
T4 267-278 CHEBI_64360 denotes tocilizumab
T5 404-412 DOID_0080600 denotes COVID-19
T6 503-514 CHEBI_64360 denotes tocilizumab
T7 584-592 HP_0012826 denotes moderate
T8 596-602 HP_0012828 denotes severe
T9 603-611 DOID_0080600 denotes COVID-19
T17 685-692 DOID_0080600 denotes D-dimer
T18 707-725 DOID_0080600 denotes C reactive protein
T11 761-782 CHEBI_24996 denotes lactate dehydrogenase
R0 T14 T2 effect inflammatory response,severity
R1 T14 T7 effect inflammatory response,moderate
R10 T3 T6 negative COVID-19,tocilizumab
R11 T3 T10 effect COVID-19,ferritin
R13 T5 T0 no_relation COVID-19,role
R14 T5 T4 negative COVID-19,tocilizumab
R15 T5 T6 negative COVID-19,tocilizumab
R16 T5 T10 effect COVID-19,ferritin
R18 T9 T0 no_relation COVID-19,role
R19 T9 T4 negative COVID-19,tocilizumab
R2 T14 T8 effect inflammatory response,severe
R20 T9 T6 negative COVID-19,tocilizumab
R21 T9 T10 no_relation COVID-19,ferritin
R23 T12 T0 no_relation COVID-19,role
R24 T12 T4 negative COVID-19,tocilizumab
R25 T12 T6 negative COVID-19,tocilizumab
R26 T12 T10 effect COVID-19,ferritin
R28 T15 T0 no_relation COVID-19,role
R29 T15 T4 negative COVID-19,tocilizumab
R3 T1 T0 no_relation disease,role
R30 T15 T6 negative COVID-19,tocilizumab
R31 T15 T10 effect COVID-19,ferritin
R33 T16 T3 effect Pro-inflammatory markers,COVID-19
R34 T4 T3 negative tocilizumab,COVID-19
R4 T1 T4 negative disease,tocilizumab
R5 T1 T6 negative disease,tocilizumab
R6 T1 T10 effect disease,ferritin
R8 T3 T0 no_relation COVID-19,role
R35 T1 T3 effect disease,COVID-19
R7 T1 T11 effect disease,lactate dehydrogenase
R32 T15 T11 effect COVID-19,lactate dehydrogenase
R27 T12 T11 effect COVID-19,lactate dehydrogenase
R22 T9 T11 effect COVID-19,lactate dehydrogenase
R17 T5 T11 effect COVID-19,lactate dehydrogenase
R12 T3 T11 effect COVID-19,lactate dehydrogenase
R36 T3 T17 effect COVID-19,D-dimer
R37 T3 T18 effect COVID-19,C reactive protein

ENG_RE_mabarros

Id Subject Object Predicate Lexical cue
T0 44-48 CHEBI_50906 denotes role
T1 56-63 DOID_4 denotes disease
T10 736-744 CHEBI_82594 denotes ferritin
T12 930-938 DOID_0080600 denotes COVID-19
T14 1562-1583 GO_0006954 denotes inflammatory response
T15 1587-1595 DOID_0080600 denotes COVID-19
T2 64-72 HP_0012824 denotes severity
T3 90-98 DOID_0080600 denotes COVID-19
T4 267-278 CHEBI_64360 denotes tocilizumab
T5 404-412 DOID_0080600 denotes COVID-19
T6 503-514 CHEBI_64360 denotes tocilizumab
T7 584-592 HP_0012826 denotes moderate
T8 596-602 HP_0012828 denotes severe
T9 603-611 DOID_0080600 denotes COVID-19
R0 T14 T2 no_relation inflammatory response,severity
R1 T14 T7 no_relation inflammatory response,moderate
R10 T3 T6 effect COVID-19,tocilizumab
R11 T3 T10 effect COVID-19,ferritin
R13 T5 T0 no_relation COVID-19,role
R14 T5 T4 effect COVID-19,tocilizumab
R15 T5 T6 effect COVID-19,tocilizumab
R16 T5 T10 effect COVID-19,ferritin
R18 T9 T0 no_relation COVID-19,role
R19 T9 T4 effect COVID-19,tocilizumab
R2 T14 T8 no_relation inflammatory response,severe
R20 T9 T6 effect COVID-19,tocilizumab
R21 T9 T10 effect COVID-19,ferritin
R23 T12 T0 no_relation COVID-19,role
R24 T12 T4 effect COVID-19,tocilizumab
R25 T12 T6 no_relation COVID-19,tocilizumab
R26 T12 T10 no_relation COVID-19,ferritin
R28 T15 T0 no_relation COVID-19,role
R29 T15 T4 effect COVID-19,tocilizumab
R30 T15 T6 no_relation COVID-19,tocilizumab
R31 T15 T10 no_relation COVID-19,ferritin
R4 T1 T4 effect disease,tocilizumab
R5 T1 T6 effect disease,tocilizumab
R6 T1 T10 effect disease,ferritin
R8 T3 T0 no_relation COVID-19,role
R9 T3 T4 effect COVID-19,tocilizumab